Senseonics, Welldoc to Launch AI-Enhanced Eversense 365 App in H2 2026
SENS•Senseonics has partnered with AI-health leader Welldoc to co-develop an upgraded Eversense 365 mobile app featuring Apple Health, Google Health Connect and twiist Automated Insulin Delivery integration. The enhanced interface, improved workflows and potential AI-driven bolus calculations will debut in the US in H2 2026 and Europe in early 2027.
1. Strategic Partnership
Senseonics has formalized a collaboration with Welldoc to design and build a next-generation mobile application for its one-year implantable CGM system, Eversense 365. The deal leverages Welldoc’s AI-powered health platform to elevate user experience and long-term product value.
2. App Features and Launch Schedule
The redesigned app will retain existing monitoring capabilities while adding seamless linkage to Apple Health, Google Health Connect and the twiist Automated Insulin Delivery System. It features a revamped interface for sensor pairing, data sync and alert displays, targeting a US release in the second half of 2026 and broader European availability in early 2027.
3. Future Feature Roadmap
Following the initial rollout, Senseonics and Welldoc plan a cadence of updates to introduce AI-driven functionalities such as CGM-informed bolus calculations, medication management tools, metabolic tracking and patient education resources to further differentiate the Eversense experience.
